Insider trades

Janeen Noel Doyle, Chief Officer of Janux Therapeutics JANX, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $56.9K. The latest trade was on 06/02.

Janeen Noel Doyle

Chief Corp. & Bus. Dev. Ofcr
First filing
25/06/04
Trades
5 trades
Buys / sales
0 / 1
12-month net buying
−$56.9K
Last trade
06/02

Trading activity

Transactions

Trade type
Open-market sale06/0206/044,059 sh$14.03$56,947.77−5.1%